Analysis of the Type VI secretion system and microbiological characteristics of hypervirulent Klebsiella pneumoniae causing urinary tract infections
Abstract
INTRODUCTION
This study aimed to evaluate the Type VI secretion system (T6SS) and microbiological features in hypervirulent Klebsiella pneumoniae (hvKP) causing urinary tract infections (UTIs) in hospitalized adults.
METHODOLOGY
This retrospective, observational analysis encompassed 167 inpatients with UTIs caused by KP. The study investigated disease prevalence, antimicrobial susceptibility, gene carriage rates, and competition indices. Strains were classified as classic KP (cKP), T6SS-positive hvKP, or T6SS-negative hvKP, and compared for clinical traits, antimicrobial susceptibilities, and virulence gene carriage. Furthermore, the bacterial competition index of T6SS-positive hvKP strains was assessed through in vitro cultivation.
RESULTS
Of 167 patients, 82 had hvKP and 85 had cKP. hvKP had higher rates of thrombosis, immunotherapy, hypoproteinemia, and longer hospital stays (p < 0.05). The 30-day mortality was 29.26% for hvKP vs. 12.94% for cKP (p = 0.045). hvKP showed highest resistance to cefuroxime (81.70%) and cKP to ampicillin/sulbactam (56.47%), with low resistance to tigecycline. The resistance to carbapenems (carbapenem-resistant KP, CR-KP) was significantly higher in hvKP compared to cKP (30.48% vs 16.47%, p = 0.032). Aerobactin and iroB differed between hvKP and cKP. T6SS-positive hvKP had higher rates of thrombosis and immunotherapy (p < 0.05). The 30-day mortality was 9.52% for T6SS-positive vs. 36.06% for T6SS-negative (p = 0.043). T6SS-positive hvKP strains…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.